Detalhe da pesquisa
1.
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
N Engl J Med
; 386(12): 1143-1154, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320644
2.
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.
Lancet
; 401(10371): 105-117, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495879
3.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 401(10390): 1773-1785, 2023 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086745
4.
Trastuzumab Deruxtecan for Breast Cancer. Reply.
N Engl J Med
; 386(24): 2347, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704496
5.
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis.
Cancer Discov
; 12(12): 2754-2762, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255231
6.
Design, characterization, and intracellular trafficking of biofunctionalized chitosan nanomicelles.
Biointerphases
; 15(6): 061003, 2020 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33187397
7.
Assessment of Matrix Metalloproteinases by Gelatin Zymography.
Methods Mol Biol
; 1406: 151-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26820952
8.
Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression.
Oncotarget
; 7(38): 61107-61120, 2016 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27531896
9.
MMP Inhibitors: Past, present and future.
Front Biosci (Landmark Ed)
; 20(7): 1164-78, 2015 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25961551
10.
Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas.
Genes Dis
; 2(`1): 26-34, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26097889
11.
Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP).
Oncotarget
; 6(24): 20723-39, 2015 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26009875